Loengard Anna U 4
4 · CLOVER HEALTH INVESTMENTS, CORP. /DE · Filed Mar 18, 2024
Insider Transaction Report
Form 4
Loengard Anna U
Director
Transactions
- Purchase
Class A Common Stock
2024-03-14$0.73/sh+137,000$100,010→ 538,841 total - Purchase
Class A Common Stock
2024-03-14$0.73/sh+13,625$9,946→ 15,125 total(indirect: By Daughter in a Custodial Account)
Holdings
- 10,000(indirect: By Spouse)
Class A Common Stock
- 1,300(indirect: By Son in a Custodial Account)
Class A Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average purchase price. These shares were purchased on the Transfer Date in multiple transactions at prices ranging from $0.73 to $0.74 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.